The role(s) of protein kinases in the regulation of G protein-dependent activation of phosphatidylinositolspecific phospholipase C by tumor necrosis factor-alpha was investigated in the osteoblast cell line MC3T3-E1. We have previously reported the stimulatory effects of tumor necrosis factor-alpha
Tiludronate inhibits interleukin-6 synthesis in osteoblasts: Inhibition of phospholipase D activation in MC3T3-E1 cells
β Scribed by Haruhiko Tokuda; Osamu Kozawa; Atsushi Harada; Toshihiko Uematsu
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 82 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
β¦ Synopsis
In previous studies, we have reported that PGF 2β£ stimulates phosphoinositide hydrolysis by phospholipase C and phosphatidylcholine hydrolysis by phospholipase D through heterotrimeric GTP-binding protein in osteoblast-like MC3T3-E1 cells, and that PGF 2β£ and PGE 1 induce interleukin-6 (IL-6) synthesis via activation of protein kinase C and protein kinase A, respectively. In the present study, we investigated the effect of tiludronate, a bisphosphonate known to inhibit bone resorption, on the PGF 2β£ -and PGE 1 -induced IL-6 synthesis in these cells. Tiludronate significantly suppressed the PGF 2β£ -induced IL-6 secretion in a dose-dependent manner in the range between 0.1 and 30 Β΅M. However, the IL-6 secretion induced by PGE 1 or (Bu) 2 cAMP was hardly affected by tiludronate. The choline formation induced by PGF 2β£ was reduced by tiludronate dose-dependently in the range between 0.1 and 30 Β΅M. On the contrary, tiludronate had no effect on PGF 2β£ -induced formation of inositol phosphates. Tiludronate suppressed the choline formation induced by NaF, known as an activator of heterotrimeric GTP-binding protein. However, tiludronate had little effect on the formation of choline induced by TPA, a protein kinase C activator. Tiludronate significantly inhibited the NaF-induced IL-6 secretion in human osteoblastic osteosarcoma Saos-2 cells. These results strongly suggest that tiludronate inhibits PGF 2β£ -induced IL-6 synthesis via suppression of phosphatidylcholinehydrolyzing phospholipase D activation in osteoblasts, and that the inhibitory effect is exerted at the point between heterotrimeric GTP-binding protein and phospholipase D.
π SIMILAR VOLUMES
We have previously shown that CD4 ligands inhibit interleukin-2 (IL-2) production and T cell proliferation in human peripheral CD4 + T lymphocytes, in an MHC-independent way. Two major pathways implicated in T cell activation are inhibited by binding of CD4 ligands to the CD4 molecule, i. e. Ca 2+ s
We investigated the regulatory mechanism of interleukin-6 (IL-6) synthesis induced by interleukin-1 (IL-1) in osteoblast-like MC3T3-E1 cells. IL-1 stimulated the secretion of IL-6 in a dose-dependent manner in the range between 0.1 and 100 ng/ml. Staurosporine and calphostin C, inhibitors of protein